We are delighted to invite you to our 20th Migraine Trust International Symposium in London from 5-8 September 2024.

As we approach this significant milestone, we will continue to build on our successes to deliver a unique meeting for the international headache and migraine community. We are planning a modern and dynamic live event that will foster engaging interactions and enriching experiences for all attendees.

Dating back to its inception in 1976, MTIS holds the distinction of being the world’s longest-established headache conference. Our aim has always been to unite clinicians and scientists interested in headache research while maintaining a strong connection with our most valuable stakeholders: headache patients, particularly those affected by migraine, and their carers.
The Migraine Trust International Symposium is an opportunity to showcase groundbreaking discoveries in mechanisms, innovative treatments, and critical insights into the impacts of migraine and other headache disorders, benefitting all attendees. With the allure of London as our backdrop and the unwavering support of a globally recognised patient-driven organisation – The Migraine Trust – our meetings have consistently drawn a diverse and international audience.

For MTIS 2024, we will provide an outstanding scientific programme, including enriching teaching courses and a platform to present the latest research. As part of our commitment to our patient and advocate community, a public programme on the final afternoon will offer an opportunity to connect and disseminate knowledge to a wider audience, raising awareness and understanding of migraine-related challenges and presenting a synopsis of the Symposium content.

Industry-driven satellites will showcase new and exciting therapies, providing valuable insights into cutting-edge advancements, pioneering therapies, and innovations in the field. These symposia will offer expert content, foster collaboration and inspire progress in migraine research and patient care.

Register now to join us for MTIS 2024 for a truly extraordinary and transformative scientific meeting.

Together, let us create a meeting that advances our collective mission of alleviating the burden of migraine and improving the lives of those affected.

We look forward to seeing you in London.

Peter Goadsby
Chair of the Scientific Committee MTIS

Rob Music
CEO, The Migraine Trust

The MTIS Committee

The MTIS 2024 programme is selected by an international panel of academics, medical practitioners, and researchers with diverse specialities in the field of headaches and migraines.

The Scientific Committee

  • Chair: Peter Goadsby, Kings College, UK
  • Shazia Afridi, Guy’s and St Thomas’ Foundation Trust, UK
  • Rami Burstein,  Harvard Medical School, USA
  • Lars Edvinsson, University Hospital of Lund, Sweden
  • Amy Gelfand, UC San Francisco, USA
  • Raquel Gil-Gouveia, Hospital da Luz, Portugal
  • Philip Holland, Kings College, UK
  • Arne May, University of Hamburg, Germany
  • Koen Paemeleire, Ghent University Hospital, Belgium
  • Mario Peres, São Paulo Headache Center, Brazil
  • Patricia Pozo-Rosich, Vall d’Hebron University Hospital, Spain
  • Todd Schwedt, Mayo Clinic, USA
  • Gisela Terwindt, Leiden University Medical Centre, Netherlands

Migraine Trust International Symposium

c/o Conference Collective Ltd
8 Waldegrave Road
TW11 8GT
United Kingdom


Cookies & Privacy